WOBURN, Mass. and DURHAM, N.C., July 21 /PRNewswire/ -- AdvanDx and bioMerieux, Inc. today announced Orlando Regional Medical Center (ORMC), which is part of Orlando Health, has implemented the PNA FISH(R) tests from AdvanDx to identify bloodstream pathogens 1 to 2 days earlier to help their physicians, pharmacists and nurses improve care and outcomes for patients with bloodstream infections.
Every year, 350,000 patients contract bloodstream infections in the United States causing over 90,000 deaths and significant costs to the healthcare system. Rapid and accurate identification of the causative pathogen is crucial to ensuring appropriate antibiotic therapy and improving patient outcomes in this critical situation. Conventional diagnostic methods can take 48 hours or longer forcing physicians to treat patients empirically with broad-spectrum antibiotics that may prove to be ineffective or unnecessary and can lead to long-term resistance and mortality.
AdvanDx's PNA FISH tests employ unique technology that detects bacteria's genetic material to provide identification results in just over 2 hours. "The fast tests have enabled the microbiology lab to provide results 1 to 2 days sooner for such serious pathogens as Staphylococcus aureus, other staphylococci, Candida albicans and Candida glabrata," said Valerie Hoover, Microbiology Supervisor at ORMC.
Clinical trials conducted at hospitals in the United States have shown that implementing PNA FISH and delivering fast results to clinicians directed earlier, effective antibiotic therapy, reduced mortality rates and improved hospital operational efficiency by reducing hospital length of stay, bed utilization, and pharmacy and lab costs related to unnecessary antibiotic use. (1,2,3)
"We are excited about this latest diagnostic tool and we are already seeing improvements in how physicians
Copyright©2009 PR Newswire.
All rights reserved